Sage Therapeutics Inc. buy Ackermann
Start price
11.06.24
/
0%
€10.50
Target price
11.06.25
-
Performance (%)
7.67%
Price
19.07.24
€11.31
Summary
This prediction is currently active. With a performance of 7.67%, the BUY prediction by Ackermann for Sage Therapeutics Inc. is trending in the right direction. This prediction currently runs until 11.06.25. The prediction end date can be changed by Ackermann at any time. This prediction was marked as speculative and is excluded from Ackermann's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sage Therapeutics Inc. | 4.531% | 4.531% |
| iShares Core DAX® | -0.543% | 1.491% |
| iShares Nasdaq 100 | -2.696% | -1.235% |
| iShares Nikkei 225® | -2.863% | 2.491% |
| iShares S&P 500 | -1.105% | 0.013% |
According to Ackermann what are the pros and cons of Sage Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Cons
Few uniques
Comments by Ackermann for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Buy Sage Therapeutics Inc.